These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11275937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization.
    Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA.
    J Invasive Cardiol; 2003 Mar; 15(3):133-8. PubMed ID: 12612387
    [Abstract] [Full Text] [Related]

  • 3. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Vijayalakshmi K, Williams D, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.
    J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE, Investigators of the CARE Study.
    Circulation; 2007 Jun 26; 115(25):3189-96. PubMed ID: 17562951
    [Abstract] [Full Text] [Related]

  • 7. Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography.
    Wisneski JA, Gertz EW, Dahlgren M, Muslin A.
    Am J Cardiol; 1989 Feb 15; 63(7):489-95. PubMed ID: 2916435
    [Abstract] [Full Text] [Related]

  • 8. Cardiac hemodynamic effects of iodixanol, iopamidol, and ioxaglate following left coronary injections in anesthetized dogs.
    Morris TW, Dukovic D, Pagani E.
    Acad Radiol; 1995 Jan 15; 2(1):33-7. PubMed ID: 9419521
    [Abstract] [Full Text] [Related]

  • 9. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
    Weiland FL, Marti-Bonmati L, Lim L, Becker HC.
    Acta Radiol; 2014 Jul 15; 55(6):715-24. PubMed ID: 24060817
    [Abstract] [Full Text] [Related]

  • 10. Allergic-type adverse reactions to low osmolality contrast media in patients with a history of allergy or asthma.
    Simon MR.
    Invest Radiol; 1995 May 15; 30(5):285-90. PubMed ID: 7558732
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME, Esplugas E, Piessens J, Rasch W.
    Circulation; 2000 Jan 18; 101(2):131-6. PubMed ID: 10637198
    [Abstract] [Full Text] [Related]

  • 13. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):924-30. PubMed ID: 16949481
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
    Davidson CJ, Laskey WK, Hermiller JB, Harrison JK, Matthai W, Vlietstra RE, Brinker JA, Kereiakes DJ, Muhlestein JB, Lansky A, Popma JJ, Buchbinder M, Hirshfeld JW.
    Circulation; 2000 May 09; 101(18):2172-7. PubMed ID: 10801758
    [Abstract] [Full Text] [Related]

  • 16. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G, Baber U, Mastoris I, Vlachojannis GJ, Yu J, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Nikolsky E, Wong SC, Theodoropoulos KN, Dangas GD, Mehran R.
    Catheter Cardiovasc Interv; 2016 Mar 09; 87(4):703-9. PubMed ID: 26481591
    [Abstract] [Full Text] [Related]

  • 17. A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
    Sutton AG, Ashton VJ, Campbell PG, Price DJ, Hall JA, de Belder MA.
    Catheter Cardiovasc Interv; 2002 Nov 09; 57(3):346-52. PubMed ID: 12410513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC, Lyon SG, Berry CC.
    Radiology; 1997 Jun 09; 203(3):605-10. PubMed ID: 9169676
    [Abstract] [Full Text] [Related]

  • 20. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate.
    Murakami R, Tajima H, Kumazaki T, Yamamoto K.
    Acta Radiol; 1998 Jul 09; 39(4):368-71. PubMed ID: 9685820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.